Pascal Lamy, 06 November 2020

The Access to COVID-19 Tools Accelerator – a collaboration between WHO, the French president, the European Commission, the Gates Foundation and other countries – was launched in April 2020 to accelerate the development and production of, and equitable access to, COVID-19 tests, treatments, and vaccines. In this column, Pascal Lamy argues that while efforts are underway to mobilise public and private grant contributions to fund the initiative, it is unlikely that they will raise the amounts required to deal with the most urgent needs. Innovative ways of financing, which are already available for other aid programmes, will also be needed to ensure that the populations of the world’s poorer countries are not deprived of access to vaccines within a few months.



CEPR Policy Research